메뉴 건너뛰기
Pharmacoepidemiology and Drug Safety
Volumn 16, Issue 3, 2007, Pages 349-351
Reporting adverse events in randomized controlled trials
Author keywords

Adverse effects; Drug therapy; Randomized controlled trials
Indexed keywords

ADVERSE OUTCOME; ARTICLE; CLINICAL RESEARCH; CORRELATION ANALYSIS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RISK REDUCTION; UNITED STATES; WRITING;
EID: 33947266027     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1310     Document Type: Article
Times cited : (15)
References (9)
  • 1
    • 0032522873 scopus 로고    scopus 로고
    • Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
    • Lasarou J, Pomeranz B, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
    • (1998) JAMA , vol.279 , pp. 1200-1205
    • Lasarou, J.1    Pomeranz, B.2    Corey, P.N.3
  • 2
    • 9444255722 scopus 로고    scopus 로고
    • Improving the quality of reporting randomized controlled trials: The CONSORT statement
    • Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-639.
    • (1996) JAMA , vol.276 , pp. 637-639
    • Begg, C.1    Cho, M.2    Eastwood, S.3
  • 3
    • 0037024265 scopus 로고    scopus 로고
    • Reporting number needed to treat and absolute risk reduction in randomized controlled trials
    • Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 2002; 287: 2813-2814.
    • (2002) JAMA , vol.287 , pp. 2813-2814
    • Nuovo, J.1    Melnikow, J.2    Chang, D.3
  • 4
    • 0032988978 scopus 로고    scopus 로고
    • Influence of data display formats on physician investigator's decisions to stop clinical trials
    • Elting LS, Martin CG, Cantor SB, Rubenstein EB. Influence of data display formats on physician investigator's decisions to stop clinical trials. BMJ 1999; 318: 1527-1531.
    • (1999) BMJ , vol.318 , pp. 1527-1531
    • Elting, L.S.1    Martin, C.G.2    Cantor, S.B.3    Rubenstein, E.B.4
  • 5
    • 0035901579 scopus 로고    scopus 로고
    • The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
    • Altman DG, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
    • (2001) Ann Intern Med , vol.134 , pp. 663-694
    • Altman, D.G.1
  • 6
    • 33947254872 scopus 로고    scopus 로고
    • Reporting of adverse drug reactions in randomized controlled trials - A systematic survey
    • Loke YK, Derry S. Reporting of adverse drug reactions in randomized controlled trials - a systematic survey. http://www.biomedcentral.com/ 1472-6904/1/3
    • Loke, Y.K.1    Derry, S.2
  • 7
    • 0035941525 scopus 로고    scopus 로고
    • Completeness of safety reporting in randomized trials. An evaluation of 7 medical areas
    • Ioannidis JPA, Lau J. Completeness of safety reporting in randomized trials. An evaluation of 7 medical areas. JAMA 2001; 285: 437-443.
    • (2001) JAMA , vol.285 , pp. 437-443
    • Ioannidis, J.P.A.1    Lau, J.2
  • 8
    • 20944435540 scopus 로고    scopus 로고
    • The research on adverse drug events and reports (RADAR) project
    • Bennett CL, et al. The research on adverse drug events and reports (RADAR) project. JAMA 2005; 293: 2131-2140.
    • (2005) JAMA , vol.293 , pp. 2131-2140
    • Bennett, C.L.1
  • 9
    • 8744229000 scopus 로고    scopus 로고
    • Better reporting of harms in randomized trials; an extension of the CONSORT statement
    • Ioannidis JPA, et al. Better reporting of harms in randomized trials; an extension of the CONSORT statement. Ann Intern Med 2004; 141; 781-788.
    • (2004) Ann Intern Med , vol.141 , pp. 781-788
    • Ioannidis, J.P.A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.